Puration and Kali Plan to Submit New Patent Applications in Conjunction with Generex Agreement
November 27 2018 - 12:38PM
InvestorsHub NewsWire
Dallas, TX -- November 27, 2018 --
Investorshub NewsWire -- Puration, Inc. (USOTC:
PURA) and Kali, Inc. (USOTC:
KALY) today announced a letter to shareholders from the
incoming CEO of Kali, Frederick Ferri, in conjunction with the
recent acquisition of his company NCM Biotech by Kali, in addition
to addressing how Kali fits into Puration’s recent announcement
with Generex (USOTC:
GNBT). Puration yesterday announced an
agreement with Generex
Biotechnology Corporation to develop and
produce NuGenerex CBD HydroHealth High Alkaline Water. The
Puration and Generex announcement detailed the agreement as part of
a larger developing agreement with US Cannabis Health.
Puration is a partner in US Cannabis Health with Kali and Nouveau
Life Pharmaceuticals (USOTC:
NOUV). Mr. Ferri’s letter provides more detail on the
value Kali brings to the Puration and Generex agreement to develop
and produce NuGenerex CBD HydroHealth High Alkaline Water.
The letter is included in its entirety
below:
Dear Kali Shareholders
–
I’m delighted to be joining you in taking
Kali in a new direction. I’ve been working for years now in
developing the science behind a cannabis extraction process in
addition to working on applications for the extracts from that
process. As you likely already know by now, the extraction
process has been patented. However, you are likely less
familiar with the research that has been conducted with various
extracts derived from the patented process. Over the coming
months you will have the opportunity to learn a good deal about the
research. You can expect to soon see the publication of
research based on the application of extracts from the patented
process in the treatment of specific conditions and diseases.
In the meantime, I encourage you to visit the new Kali website my
team has built to keep shareholders up to date on our latest
developments. The website is brand new and a work in
progress, so check back frequently. In particular, please
take time to review the section on Kali’s new business plan in
conjunction with the recent acquisition of NCM Biotech, the company
I founded:
https://www.kali-extracts.com/kaliextract-biz-plan/
The announcement yesterday between
Puration and Generex is very exciting for Kali. Let me
explain why. First, you need to know that
Puration is the only licensee of what is now Kali’s patented
cannabis extraction process. Puration has licensed the patent
for specific, non-pharmaceutical applications. In conjunction
with their license, Puration has been very successful in developing
and marketing a CBD infused bottled water called EVERx CBD Sports
Water. Second, you need to know that
Puration and Kali have formed a joint venture company called US
Cannabis Health for the purpose of developing and marketing
pharmaceutical applications and non-pharmaceutical wellness
concentrates derived from Kali’s patented extraction process.
Now understanding the relationship between Puration and Kali, know
that the announcement yesterday about the agreement between
Puration and Generex was part of a larger agreement executed
between Generex and US Cannabis Health. While Puration will
be producing the NuGenerex CBD
HydroHealth High Alkaline Water, Kali will be developing custom CBD
extracts for Puration to infuse into the NuGenerex CBD HydroHealth
High Alkaline Water.
With the
patented extraction process now under the Kali banner, we have
already developed and tested a number of different extracts as
therapies for symptoms of specific health issues. We have
accordingly already initiated the process of filing for new patents
in conjunction with our research. With the Generex agreement
announced yesterday, we will refine our existing research to
specifically target Generex’s purposes and correspondingly file
additional patent applications on behalf of Kali, Puration, US
Cannabis Health and Generex.
I anticipate
that with my letter today, you now have a better understanding of
why I am so excited for Kali and its shareholders about the
announcement yesterday by Puration and Generex. I think the
Puration and Generex shareholders should be equally excited.
I am thoroughly familiar with all of the current cannabis
extraction science in the market place and I contend that our
technology is a standout. I am confident the NuGenerex CBD
HydroHealth High Alkaline Water will be a big success. I am
even more excited by what I believe this first step with Generex
will lead to in regard to pharmaceutical applications derived from
Kali’s patented extract
process.
Sincerely,
Frederick
Ferri
To learn more
about Kali, visit www.kali-extracts.com
To learn more about Puration, visit
www.puraitoninc.com
Disclaimer/Safe
Harbor:
This news release contains forward-looking
statements within the meaning of the Securities Litigation Reform
Act. The statements reflect the Company's current views with
respect to future events that involve risks and uncertainties.
Among others, these risks include the expectation that any of the
companies mentioned herein will achieve significant sales, the
failure to meet schedule or performance requirements of the
companies' contracts, the companies' liquidity position, the
companies' ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of
competitive pricing. In the light of these uncertainties, the
forward-looking events referred to in this release might not occur.
These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat,
cure, or prevent any disease.
Kali, Inc.
Frederick
Ferri
ir@kali-extracts.com
214
210-0459
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350
Nouveau Life Pharmaceuti... (PK) (USOTC:NOUV)
Historical Stock Chart
From Aug 2024 to Sep 2024
Nouveau Life Pharmaceuti... (PK) (USOTC:NOUV)
Historical Stock Chart
From Sep 2023 to Sep 2024